The Efficacy of Moxifloxacin-Containing Triple Therapy after Standard Triple, Sequential, or Concomitant Therapy Failure for Helicobacter pylori Eradication in Korea
Explore this paper's citation graph
Summary
Moxifloxacin-containing triple therapy, a recommended second-line treatment for initial concomitant or sequential therapy failure, had insufficient efficacy.
- Type
- dissertation
- Published
- 2014-04-23
- Cited by
- 15
- References
- 32
- OpenAlex
- https://openalex.org/W25368747
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:9882408
Keywords
Political science, Humanities, Philosophy
References
- Effect of Helicobacter pylori density on inflammatory activity in stomach.
- Second‐Line Treatment for Helicobacter pylori Infection: 10‐day Moxifloxacin‐Based Triple Therapy versus 2‐week Quadruple Therapy
- Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis
- Primary Antibiotic Resistance of Helicobacter pylori Isolated from Beijing Children
- Ten‐day sequential therapy is more effective than proton pump inhibitor‐based therapy in Korea: A prospective, randomized study
- High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial
- Moxifloxacin‐Containing Triple Therapy as Second‐Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate
- Epidemiology of Helicobacter pylori Infection and Public Health Implications
- Moxifloxacin‐Containing Triple Therapy versus Bismuth‐Containing Quadruple Therapy for Second‐Line Treatment of Helicobacter pylori Infection: A Meta‐Analysis
- [Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
- Levofloxacin-Based Triple Therapy versus Bismuth-Based Quadruple Therapy for Persistent Helicobacter pylori Infection: A Meta-Analysis
- Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate‐based therapies
- Systematic review and meta‐analysis: levofloxacin‐based rescue regimens after Helicobacter pylori treatment failure
- Low Efficacy Rate of Moxifloxacin‐Containing Helicobacter pylori Eradication Treatment: In an Observational Study in a Turkish Population
- Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial
- Moxifloxacin‐based strategies for first‐line treatment of Helicobacter pylori infection
- Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection.
- Helicobacter pylori ‘rescue’ regimen when proton pump inhibitor‐based triple therapies fail
- Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure
- Moxifloxacin
Cited by
- Treatment of Helicobacter pylori Infection 2013
- Treatment of Helicobacter pylori Infection 2015
- Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity.
- Efficiency of Moxifloxacin in the Treatment of Helicobacter pylori Infection
- Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
- Recent Update on Third-line Helicobacter pylori Eradication
- Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial
- IV Spanish Consensus Conference on Helicobacter pylori infection treatment.
- Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
- IV Spanish Consensus Conference on Helicobacter pylori infection treatment.
- Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis
- Quinolone-based first, second and third-line therapies for Helicobacter pylori
- Update on quinolone-containing rescue therapies for Helicobacter pylori infection
- Treatment of Helicobacter pylori Infection in Korea: An Evidence-Based Analysis of the Upcoming 2025 Guideline
- Efficacy and safety of antibiotic regimens for Helicobacter pylori eradication: a systematic review and meta-analysis
Related papers
No related papers recorded.